Five Steps to Address the Pain Points of Co-Pay Accumulator Programs

Posted by Howard Deutsch on Wed, Jan 31, 2018

In the cat-and-mouse co-pay card game, payers have made their next move. Pharmacy benefit managers have been promoting “co-pay accumulator” programs to plan sponsors as a way to reduce specialty drug spending. Left alone, these programs will result in confused patients who are less likely to adhere to their medications, and high costs for pharmaceutical manufacturers. Pharma companies need to respond.


>
Read More

The State of the Union Between Pharma and Tech

Posted by Vickye Jain on Tue, Jan 09, 2018

Sandeep Varma and Raghav Sharma co-wrote this blog post with Vickye Jain.

Pharmaceutical companies have a reputation for lagging behind other industries when it comes to technology, but that reputation now seems unwarranted in many respects. As technology professionals who work with pharmaceutical clients, we feel an obligation not only to share how pharma is innovating, but also to bring those innovations back to pharma. At two recent industry events, the Strata Data Conference in Singapore and the Spark Summit in Ireland, we learned a great deal from the presentations that we attended, and almost just as much from the audience’s reaction to our own presentations. Here are our top three takeaways from these conferences:


>
Read More

Who Moved Pharma’s Cheese?

Posted by Steve Bull on Fri, Sep 22, 2017

Do you remember the book Who Moved My Cheese? that was popular in the 1990s? It tells the story of two people and two mice who live in a maze and thrive on a seemingly endless supply of cheese. The parable resonated with many of us—including me—both in business settings and in our personal lives. After following the four characters’ varying reactions to the possibility of their “cheese” source disappearing, you can’t help but turn the lens on yourself and ask, How would I deal with unexpected change?


>
Read More